Xponance Inc. Raises Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Xponance Inc. boosted its holdings in Oscar Health, Inc. (NYSE:OSCR) by 7.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,423 shares of the company’s stock after purchasing an additional 1,029 shares during the period. Xponance Inc.’s holdings in Oscar Health were worth $202,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of OSCR. JPMorgan Chase & Co. boosted its holdings in Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. BIT Capital GmbH boosted its holdings in Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after purchasing an additional 4,396,872 shares during the last quarter. Deerfield Management Company L.P. Series C boosted its holdings in Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after purchasing an additional 3,983,325 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its holdings in Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after purchasing an additional 2,151,256 shares during the last quarter. Finally, Thrive Capital Management LLC boosted its holdings in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 3.3%

Shares of NYSE OSCR opened at $13.41 on Monday. The company has a market cap of $3.42 billion, a price-to-earnings ratio of 47.89 and a beta of 1.90. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22. The stock’s 50 day simple moving average is $16.21 and its 200 day simple moving average is $14.92.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.09. The business had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business’s revenue was up 42.2% on a year-over-year basis. During the same quarter last year, the business posted $0.62 EPS. Equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Ratings Changes

A number of brokerages recently commented on OSCR. Barclays assumed coverage on Oscar Health in a report on Wednesday, July 2nd. They issued an “underweight” rating and a $17.00 price target for the company. UBS Group reaffirmed a “sell” rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Piper Sandler downgraded Oscar Health from an “overweight” rating to a “neutral” rating and set a $14.00 target price on the stock. in a report on Monday, July 14th. Raymond James Financial downgraded Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Finally, Wells Fargo & Company downgraded Oscar Health from an “equal weight” rating to an “underweight” rating and reduced their target price for the stock from $16.00 to $10.00 in a report on Friday, July 11th. Five analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $12.92.

Insider Activity

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the sale, the director owned 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.